Main sector:
Pharma (fully integrated)
Subsectors:
Antibodies
Anti-infectives
Cell therapy
Small molecule therapeutics
Antibody-drug-conjugate
Indications:
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Products
In development: 82
On the market: 6
Description:
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures, and commercializes therapies for viral diseases, infectious diseases, and cancer utilized proprietary "combinatorial chemistry" technology to discover lead therapeutic and diagnostic compounds. The company's primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions.
